Webinar: the Cutting-edge qPCR Approach to Single-cell Expression Profiling
News Jun 24, 2013
Integrated DNA Technologies (IDT) has teamed with Professor Mikael Kubista, a pioneer of advanced qPCR methods, to host an informative webinar complete with industry-leading techniques and advice.
The webinar entitled ‘Single Cell Expression Profiling - Breaking Down Biological Complexity’ will be held on 25 June at two different times (0700 and 1300 Central Standard Time), and will detail the novel qPCR-based workflow developed by Professor Kubista for the expression profiling of single cells.
Attendees will find out about the important experimental design aspects and gain first-hand insight into the work of Professor Kubista’s group, including their research into the activation of astrocytes following brain trauma in mice.
The use of single-cell expression profiling has revealed a surprisingly large variation in the number of transcripts among cells from seemingly homogenous tissue, and also between same cell types in culture, emphasizing the risk of measuring combined expression profiles and averaging the responses to environmental changes.
Instead, the webinar explains how single-cell expression profiling provides researchers with a method to explore the true biological properties of cells in a sample, enabling distinct gene expression profiles for distinguishing between cell types, subtypes and subpopulations of cells.
The webinar will also discuss intracellular expression profiling and multianalyte single-cell profiling, allowing the simultaneous measurements of DNA, mRNA, microRNA, IncRNA and protein in the same cell.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.